Literature DB >> 4753242

Cell-mediated immune response in primary biliary cirrhosis to a protein fraction from human bile.

A L Eddleston, I G McFarlane, C G Mitchell, W D Reed, R Williams.   

Abstract

Cell-mediated immune responses to a protein fraction of human bile have been demonstrated, using the leucocyte migration test, in eight out of 10 patients with primary biliary cirrhosis but in only three out of nine with active chronic hepatitis. In the latter condition sensitization to a liver-specific hepatocellular antigen was found more frequently (five out of nine patients) than in primary biliary cirrhosis (two out of 10). These results, as well as the granuloma formation observed histologically, suggest that the initial bile duct lesion in primary biliary cirrhosis may be associated with a cell-mediated response to antigens-perhaps derived from bile duct epithelial cells-which may be normal constituents of hepatic bile.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4753242      PMCID: PMC1587346          DOI: 10.1136/bmj.4.5887.274

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  The local nature of immunity in tuberculosis, illustrated histochemically in dermal BCG lesions.

Authors:  A M Dannenberg; O T Meyer; J R Esterly; T Kambara
Journal:  J Immunol       Date:  1968-05       Impact factor: 5.422

2.  Impaired delayed hypersensitivity in primary biliary cirrhosis.

Authors:  S Sherlock; R A Fox; D G James; P J Scheuer; O Sharma
Journal:  Lancet       Date:  1969-05-10       Impact factor: 79.321

3.  Application of the leucocyte migration test to the diagnosis of rejection after liver transplantation.

Authors:  A L Eddleston; M G Smith; C G Mitchell; R Williams
Journal:  Transplantation       Date:  1971-07       Impact factor: 4.939

Review 4.  The concept of an 'autoallergic' hepatitis.

Authors:  D Doniach
Journal:  Proc R Soc Med       Date:  1970-05

5.  Cell-mediated immune responses in chronic liver diseases.

Authors:  M G Smith; P L Golding; A L Eddleston; C G Mitchell; A Kemp; R Williams
Journal:  Br Med J       Date:  1972-02-26

6.  Evaluation of the leucocyte migration test as a measure of delayed hypersensitivty in man. Suppression of migration inhibition by puromycin.

Authors:  C G Mitchell; M G Smith; P L Golding; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1972-08       Impact factor: 4.330

7.  Human lymphocyte migration as a parameter of hypersensitivity.

Authors:  M Soborg; G Bendixen
Journal:  Acta Med Scand       Date:  1967-02

8.  The dual necessity for delayed hypersensitivity and circulating antibody in the pathogenesis of experimental allergic orchitis in guinea-pigs.

Authors:  P C Brown; L E Glynn; E J Holborow
Journal:  Immunology       Date:  1967-09       Impact factor: 7.397

9.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

10.  A micro-method for peripheral leucocyte migration in tuberculin sensitivity.

Authors:  K Federlin; R N Maini; A S Russell; D C Dumonde
Journal:  J Clin Pathol       Date:  1971-09       Impact factor: 3.411

View more
  18 in total

Review 1.  Immunological aspects of liver disease.

Authors:  A L Eddleston; P T Donaldson; J E Hegarty; B D Reed
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Circulating tissue antigens. III. Identification and characterization of antigens of limited and of wide body is distribution in human gall bladder bile. Presence in serum of patients with acute hepatitis.

Authors:  E Espinosa
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

3.  The ultrastructure of intrahepatic bile ducts in primary biliary cirrhosis.

Authors:  Y H Xu; Z B Wu
Journal:  J Tongji Med Univ       Date:  1986

Review 4.  Mitochondrial antibodies (AMA).

Authors:  D Doniach; G Walker
Journal:  Gut       Date:  1974-08       Impact factor: 23.059

Review 5.  Antigens of the human liver.

Authors:  I G McFarlane; B M Wojcicka; R Williams
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

6.  Suppressor cell activity in primary biliary cirrhosis.

Authors:  R K Zetterman; J A Woltjen
Journal:  Dig Dis Sci       Date:  1980-02       Impact factor: 3.199

Review 7.  Immunologic effector mechanisms in hepatitis B-negative chronic active hepatitis.

Authors:  R J Klingenstein; J R Wands
Journal:  Springer Semin Immunopathol       Date:  1980-12

8.  Cell-mediated immunity to liver antigen in toxic liver injury. I. Occurrence and specificity.

Authors:  C I Smith; W G Cooksley; L W Powell
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

9.  Cellular immune responses to salivary antigens in autoimmune liver disease with sicca syndrome.

Authors:  I G McFarlane; B M Wojcicka; D C Tsantoulas; C Funk; B Portmann; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

10.  Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release.

Authors:  E Fernandez-Cruz; P Escartin; A Bootello; M Kreisler; J M Segovia de Arana
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.